Neuehealth Stock Analysis
NEUE Stock | 6.56 0.04 0.61% |
NeueHealth is fairly valued with Real Value of 6.82 and Target Price of 7.0. The main objective of NeueHealth stock analysis is to determine its intrinsic value, which is an estimate of what NeueHealth is worth, separate from its market price. There are two main types of NeueHealth's stock analysis: fundamental analysis and technical analysis.
The NeueHealth stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NeueHealth's ongoing operational relationships across important fundamental and technical indicators.
NeueHealth | Build AI portfolio with NeueHealth Stock |
NeueHealth Stock Analysis Notes
About 58.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 17.65. NeueHealth had not issued any dividends in recent years. The entity had 1:80 split on the 22nd of May 2023. To find out more about NeueHealth contact George III at (612) 238-1321 or learn more at https://www.neuehealth.com.NeueHealth Quarterly Total Revenue |
|
NeueHealth Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NeueHealth's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NeueHealth or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
NeueHealth generated a negative expected return over the last 90 days | |
NeueHealth has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 936.66 M. Net Loss for the year was (99.72 M) with profit before overhead, payroll, taxes, and interest of 215.55 M. | |
NeueHealth generates negative cash flow from operations | |
NeueHealth has a poor financial position based on the latest SEC disclosures | |
About 58.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: Historical volatility pattern of NeueHealth Inc. visualized - 2025 Performance Recap AI Forecast Swing Trade Picks - Newser |
NeueHealth Upcoming and Recent Events
6th of March 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
NeueHealth Largest EPS Surprises
Earnings surprises can significantly impact NeueHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-05-04 | 2022-03-31 | -0.2418 | -0.32 | -0.0782 | 32 | ||
2021-08-03 | 2021-06-30 | -0.1598 | -0.28 | -0.1202 | 75 | ||
2022-08-10 | 2022-06-30 | -0.3225 | -0.45 | -0.1275 | 39 |
NeueHealth Environmental, Social, and Governance (ESG) Scores
NeueHealth's ESG score is a quantitative measure that evaluates NeueHealth's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of NeueHealth's operations that may have significant financial implications and affect NeueHealth's stock price as well as guide investors towards more socially responsible investments.
NeueHealth Thematic Classifications
In addition to having NeueHealth stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | InsuranceUSA Equities from Insurance industry as classified by Fama & French |
NeueHealth Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 59.2 M.NeueHealth Profitablity
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.28) | (0.30) | |
Return On Capital Employed | 0.65 | 0.42 | |
Return On Assets | (0.25) | (0.26) | |
Return On Equity | 0.31 | 0.33 |
Management Efficiency
NeueHealth has return on total asset (ROA) of (0.0196) % which means that it has lost $0.0196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8326) %, meaning that it created substantial loss on money invested by shareholders. NeueHealth's management efficiency ratios could be used to measure how well NeueHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.33, whereas Return On Tangible Assets are forecasted to decline to (0.30). At present, NeueHealth's Intangibles To Total Assets are projected to increase slightly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.39, whereas Non Current Assets Total are forecasted to decline to about 104.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (46.94) | (44.59) | |
Tangible Book Value Per Share | (55.58) | (58.36) | |
Enterprise Value Over EBITDA | (2.80) | (2.94) | |
Price Book Value Ratio | (0.14) | (0.13) | |
Enterprise Value Multiple | (2.80) | (2.94) | |
Price Fair Value | (0.14) | (0.13) | |
Enterprise Value | 2.3 B | 2.2 B |
NeueHealth benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Technical Drivers
As of the 30th of August, NeueHealth secures the Mean Deviation of 0.5335, risk adjusted performance of (0.04), and Standard Deviation of 0.7571. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeueHealth, as well as the relationship between them. Please verify NeueHealth market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if NeueHealth is priced some-what accurately, providing market reflects its recent price of 6.56 per share. Given that NeueHealth has information ratio of (0.23), we recommend you to check NeueHealth's last-minute market performance to make sure the company can sustain itself at a future point.NeueHealth Price Movement Analysis
The output start index for this execution was fourty with a total number of output elements of twenty-one. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to NeueHealth changes than the simple moving average.
NeueHealth Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NeueHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on NeueHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NeueHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NeueHealth Outstanding Bonds
NeueHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NeueHealth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NeueHealth bonds can be classified according to their maturity, which is the date when NeueHealth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
BHF 155 24 MAY 26 Corp BondUS10921U2C16 | View | |
BHF 2 28 JUN 28 Corp BondUS10921U2E71 | View | |
BRIGHTHOUSE FINL INC Corp BondUS10922NAF06 | View | |
US10922NAG88 Corp BondUS10922NAG88 | View | |
BHF 385 22 DEC 51 Corp BondUS10922NAH61 | View | |
BRIGHTHOUSE FINL INC Corp BondUS10922NAC74 | View |
NeueHealth Predictive Daily Indicators
NeueHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NeueHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NeueHealth Corporate Filings
8K | 7th of August 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 30th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 15th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 14th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 13th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 9th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 8th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
30th of April 2025 Other Reports | ViewVerify |
NeueHealth Forecast Models
NeueHealth's time-series forecasting models are one of many NeueHealth's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeueHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NeueHealth Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NeueHealth prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NeueHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NeueHealth. By using and applying NeueHealth Stock analysis, traders can create a robust methodology for identifying NeueHealth entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.11) | (0.11) | |
Operating Profit Margin | (0.11) | (0.12) | |
Net Loss | (0.14) | (0.15) | |
Gross Profit Margin | 0.21 | 0.12 |
Current NeueHealth Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NeueHealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NeueHealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.0 | Hold | 2 | Odds |
Most NeueHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NeueHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NeueHealth, talking to its executives and customers, or listening to NeueHealth conference calls.
NeueHealth Stock Analysis Indicators
NeueHealth stock analysis indicators help investors evaluate how NeueHealth stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading NeueHealth shares will generate the highest return on investment. By understating and applying NeueHealth stock analysis, traders can identify NeueHealth position entry and exit signals to maximize returns.
Begin Period Cash Flow | 375.3 M | |
Total Stockholder Equity | -434.7 M | |
Property Plant And Equipment Net | 11.2 M | |
Cash And Short Term Investments | 93.2 M | |
Cash | 83.3 M | |
50 Day M A | 6.7594 | |
Net Interest Income | -18.7 M | |
Total Current Liabilities | 710.2 M | |
Investments | 186.9 M | |
Interest Expense | 18.7 M | |
Stock Based Compensation | 70.2 M | |
Long Term Debt | 202.6 M | |
Common Stock Shares Outstanding | 8.2 M | |
Total Cashflows From Investing Activities | 186.9 M | |
Tax Provision | 2.6 M | |
Free Cash Flow | -125.5 M | |
Other Current Assets | 304.9 M | |
Accounts Payable | 130.7 M | |
Net Debt | 121.3 M | |
Other Operating Expenses | 1 B | |
Non Current Assets Total | 109.7 M | |
Liabilities And Stockholders Equity | 544.4 M | |
Non Currrent Assets Other | 27.4 M |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |